Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
- PMID: 35185777
- PMCID: PMC8850837
- DOI: 10.3389/fneur.2022.835162
Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
Abstract
The immunological mechanisms that contribute to multiple sclerosis (MS) differ between males and females. Females are 2-3 times more likely to develop MS compared to males, however the reason for this discrepancy is unknown. Once MS is established, there is a more inflammatory yet milder form of disease in females whereas males generally suffer from more severe disease and faster progression, neural degradation, and disability. Some of these differences relate to genetics, including genetic control of immune regulatory genes on the X-chromosome, as well as immune modulatory properties of sex hormones. Differences in MS development may also relate to how sex interacts with environmental risk factors. There are several environmental risk factors for MS including late-onset Epstein Barr virus infection, low serum vitamin D levels, low UV radiation exposure, smoking, obesity, and lack of physical activity. Most of these risk factors impact males and females differently, either due to biological or immunological processes or through behavioral differences. In this review, we explore these differences further and focus on how the interaction of environmental risk factors with sex hormones may contribute to significantly different prevalence and pathology of MS in males and females.
Keywords: Epstein-Barr virus (EBV); UV radiation; environmental risk factors; immune regulation; multiple sclerosis; sex hormones; vitamin D.
Copyright © 2022 Leffler, Trend, Gorman and Hart.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis.Mult Scler Relat Disord. 2020 Jun;41:101983. doi: 10.1016/j.msard.2020.101983. Epub 2020 Feb 4. Mult Scler Relat Disord. 2020. PMID: 32086164
-
Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.Acta Neurol Scand. 2015;132(199):46-55. doi: 10.1111/ane.12431. Acta Neurol Scand. 2015. PMID: 26046559 Review.
-
Environmental factors in multiple sclerosis.Expert Rev Neurother. 2013 Dec;13(12 Suppl):3-9. doi: 10.1586/14737175.2013.865866. Expert Rev Neurother. 2013. PMID: 24289836 Review.
-
Vitamin D and multiple sclerosis: An update.Mult Scler Relat Disord. 2017 May;14:35-45. doi: 10.1016/j.msard.2017.03.014. Epub 2017 Mar 29. Mult Scler Relat Disord. 2017. PMID: 28619429 Review.
-
Sex-specific environmental influences affecting MS development.Clin Immunol. 2013 Nov;149(2):176-81. doi: 10.1016/j.clim.2013.02.006. Epub 2013 Feb 21. Clin Immunol. 2013. PMID: 23498776
Cited by
-
Diffusion-Weighted Images and Contrast-Enhanced MRI in the Diagnosis of Different Stages of Multiple Sclerosis of the Central Nervous System.Cureus. 2023 Jul 10;15(7):e41650. doi: 10.7759/cureus.41650. eCollection 2023 Jul. Cureus. 2023. PMID: 37575819 Free PMC article.
-
The Influence of TEP1 and TERC Genetic Variants on the Susceptibility to Multiple Sclerosis.J Clin Med. 2023 Sep 9;12(18):5863. doi: 10.3390/jcm12185863. J Clin Med. 2023. PMID: 37762804 Free PMC article.
-
Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis.Nat Commun. 2024 Feb 28;15(1):1415. doi: 10.1038/s41467-024-44917-9. Nat Commun. 2024. PMID: 38418465 Free PMC article.
-
Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis.Transgenic Res. 2023 Apr;32(1-2):121-133. doi: 10.1007/s11248-023-00341-1. Epub 2023 Mar 17. Transgenic Res. 2023. PMID: 36930229 Free PMC article.
-
Epstein-Barr virus infection, B-cell dysfunction and other risk factors converge in gut-associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis.Clin Transl Immunology. 2022 Oct 31;11(11):e1418. doi: 10.1002/cti2.1418. eCollection 2022. Clin Transl Immunology. 2022. PMID: 36325491 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources